1190947-66-0

Basic information

• Product Name: methyl 2-chloro-4-(ethoxycarbonothioylthio)benzoate
• Synonyms: methyl 2-chloro-4-(ethoxycarbonothioylthio)benzoate
• CAS NO: 1190947-66-0
• Molecular Weight: 290.792
• Mol File: 1190947-66-0.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: methyl 2-chloro-4-(ethoxycarbonothioylthio)benzoate(CAS DataBase Reference)
• NIST Chemistry Reference: methyl 2-chloro-4-(ethoxycarbonothioylthio)benzoate(1190947-66-0)
• EPA Substance Registry System: methyl 2-chloro-4-(ethoxycarbonothioylthio)benzoate(1190947-66-0)

Safety Data

• Hazardous Substances Data: 1190947-66-0(Hazardous Substances Data)

Upstream product

• 13324-11-3 methyl 2-chloro-4-nitrobenzoate 
• 99-60-5 2-chloro-4-nitrobenzoic acid 
• 46004-37-9 methyl 4-amino-2-chlorobenzoate 
• 140-89-6 potassium ethyl xanthogenate 

Downstream Products

• 879088-84-3 methyl 2-chloro-4-mercaptobenzoate 
• 116209-31-5 2-chloro-4-mercaptobenzoic acid 

Relevant articles and documents

PIPERIDINE DERIVATIVES AS LIVER X RECEPTOR β AGONISTS, COMPOSITIONS, AND THEIR USE

Piperidine compounds of the Formular: (I) and pharmaceutically acceptable salts thereof, wherein X, Y, R 1, R 2, R 3, L, R 4, L 1, Q and R 5 are as defined herein. The compounds and pharmaceutically acceptable compositions comprising a compound thereof, are useful as Liver X-β receptor (LXRβ) agonists, and may be useful for treating or preventing pathologies related thereto. Such pathologies include, but are not limited to, inflammatory diseases and diseases characterized by defects in cholesterol and lipid metabolism, such as Alzheimer's disease.

Pyridyl inhibitors of hedgehog signalling

The invention provides novel inhibitors of hedgehog signaling that are useful as a therapeutic agents for treating malignancies where the compounds have the general formula I: wherein A, X, Y R1, R2, R3, R4, m and n are as described herein.